title: Fertility preservation in (breast) cancer patients: is it safe?
authors.forename: Hans
authors.initials: H
authors.lastname: Wildiers
authors.forename: Patrick
authors.initials: P
authors.lastname: Neven
authors.forename: Frederic
authors.initials: F
authors.lastname: Amant
authors.forename: Thomas
authors.initials: T
authors.lastname: D'hooghe
authors.forename: Robert
authors.initials: R
authors.lastname: Paridaens
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage* / Q000009:adverse effects; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D005298:Fertility; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D017273:Goserelin / Q000008:administration & dosage; D006801:Humans; D007246:Infertility / Q000517:prevention & control*; D008495:Medical Oncology; D008594:Menopause, Premature / Q000187:drug effects*; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy*; D012955:Societies, Medical; D013629:Tamoxifen / Q000008:administration & dosage
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen; D017273:Goserelin; D007987:Gonadotropin-Releasing Hormone